Medical College of Wisconsin
CTSIResearch InformaticsREDCap

The role of integrin antagonists in the treatment of inflammatory bowel disease. Expert Opin Biol Ther 2014 Dec;14(12):1815-23

Date

10/08/2014

Pubmed ID

25288228

DOI

10.1517/14712598.2014.967209

Scopus ID

2-s2.0-84910074237 (requires institutional sign-in at Scopus site)   5 Citations

Abstract

INTRODUCTION: Ulcerative colitis (UC) and Crohn's disease are chronic inflammatory diseases of the bowel associated with complex inflammatory cascades within the mucosal lining of the gut.

AREAS COVERED: INTEGRINS and their use as therapies in UC and Crohn's.

EXPERT OPINION: The anti-adhesion molecules are a welcome addition to the armamentarium of medical therapies for inflammatory bowel disease.

Author List

Beniwal-Patel P, Saha S

Author

Poonam Beniwal-Patel MD Associate Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Animals
Anti-Inflammatory Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Cell Adhesion Molecules
Colitis, Ulcerative
Crohn Disease
Gastrointestinal Agents
Humans
Inflammatory Bowel Diseases
Integrins
Leukoencephalopathy, Progressive Multifocal